A Matched Case-Control Study to Evaluate Predicted Drug Exposures and Neutropenia during Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients [0.03%]
评估valganciclovir预防给药后预测的药物暴露和儿科实体器官移植受者的中性粒细胞减少症的一项匹配病例对照研究
Mai-Uyen T Nguyen,Michael N Neely,Anders Åsberg et al.
Mai-Uyen T Nguyen et al.
Background: Neutropenia during valganciclovir (VGCV) prophylaxis for cytomegalovirus infection in pediatric solid organ transplant (pSOT) recipients is common, but it is uncertain if this toxicity is exposure-dependent. ...
Stewardship of Molecular Diagnostics in Transplant Viral Infections [0.03%]
移植病毒感染中的分子诊断 stewardship
Scott Sugden,David Reynoso,Reema Mathew et al.
Scott Sugden et al.
The transplant environment requires special considerations when testing for viral infections as immunosuppression results in atypical infection profiles. Microbes otherwise considered commensals or causing mild disease can lead to severe in...
Effect of Prophylactic Administration of Foscarnet for HHV-6 Encephalitis in Adult Single Cord Blood Transplantation [0.03%]
预防性使用磷苯泰东治疗单倍型相合外周血干细胞移植后人类β疱疹病毒6型脑炎的临床研究
Kotaro Suzuki,Junya Kanda,Tomoki Iemura et al.
Kotaro Suzuki et al.
Background: HHV-6 encephalitis is a serious complication after allogeneic hematopoietic stem cell transplantation. Whether foscarnet prophylaxis improves outcomes after unrelated cord blood transplantation (UCBT), particu...
Malaria Screening and Treatment in Hematopoietic Cell Transplant Donors and Sickle Cell Disease Candidates/Recipients: A Case Series Using Malaria Polymerase Chain Reaction Testing and a Literature Review [0.03%]
造血细胞移植供者和镰状细胞病候选者/接受者的疟疾筛查与治疗：采用疟疾聚合酶链反应检测的病例系列及文献回顾
Mary M Czech,Sanchita Das,Emily Limerick et al.
Mary M Czech et al.
Background: Malaria during hematopoietic stem cell transplant (HCT) poses serious risks. Historically, donors with potential exposure were deferred or treated empirically. Malaria PCR, the most sensitive diagnostic tool, ...
Cytomegalovirus Infection After Chimeric Antigen Receptor T-Cell Therapy or Bispecific Antibody Treatment for Hematologic Malignancies [0.03%]
CAR-T和双特异性抗体治疗后血液系统恶性肿瘤患者的巨细胞病毒感染风险
Juhui Han,So Yun Lim,Jaewon Hyung et al.
Juhui Han et al.
Background: Limited data exists on the incidence of CMV infections after chimeric antigen receptor (CAR) T-cell or bispecific antibody (BsAb) therapy for hematologic malignancies. ...
Cytomegalovirus Infection After CD-34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis [0.03%]
CD-34选择性自体造血干细胞移植治疗系统性硬化症后巨细胞病毒感染
Brennan Collis,Tanya Helms,Gwynn D Long et al.
Brennan Collis et al.
Background: Autologous hematopoietic stem cell transplantation (AHSCT) is increasingly used to treat systemic sclerosis (SSc). Data on post-AHSCT infections, including cytomegalovirus (CMV) in this population, are limited...
Acute Fever Early Post Renal Transplantation-A Call From the Tropics [0.03%]
急性发热性肾移植后早期感染——来自热带地区的一个报告
Rehna Kakkidi Rahman,Ban Hock Tan,Daniel Wagner C L Santos et al.
Rehna Kakkidi Rahman et al.
Infection with Dengue virus (DENV)is a growing concern in solid organ transplant (SOT) recipients in endemic regions. We report a 15-year-old kidney transplant recipient who developed fever and thrombocytopenia on post-transplant day five; ...
Pilot Study to Assess the Impact of UTI Recurrence on Quality of Life and Medical Utilization in Kidney Transplant Recipients [0.03%]
评估尿路感染复发对肾移植受者的生命质量及医疗利用率影响的试点研究
Sean Jung,Katherine Chen,Moosa Kazim et al.
Sean Jung et al.
Background: Recurrent urinary tract infections (rUTIs) are common in kidney transplant recipients (KTRs). We aimed to assess the impact of rUTI on medical morbidity and quality of life (QOL). ...
A Comparison of a Solid Organ Transplant Population-Specific Antibiogram With the Hospital-Wide Antibiogram [0.03%]
固体器官移植人群特异性抗菌谱与医院整体抗菌谱的比较研究
Arzina Aziz Ali,Scott Borgetti,Alan E Gross et al.
Arzina Aziz Ali et al.
Background: Solid organ transplant (SOT) recipients are vulnerable to infections with multidrug-resistant organisms, and they often do not receive adequate empiric antimicrobials for serious Gram-negative infections. Know...